Copyright
©The Author(s) 2024.
World J Gastroenterol. Aug 21, 2024; 30(31): 3705-3716
Published online Aug 21, 2024. doi: 10.3748/wjg.v30.i31.3705
Published online Aug 21, 2024. doi: 10.3748/wjg.v30.i31.3705
Case | Ballooning | Inflammation | Fat | Fibrosis | Hepatic SARS-CoV-2 PCR result |
A | 0 | 0 | 0 | 0 | - |
B | 0 | 0 | 1 | 3 | + |
C | 0 | 0 | 1 | 2 | + |
D | 0 | 0 | 1 | 0 | - |
E | 0 | 0 | 0 | 0 | + |
F | 0 | 0 | 0 | 1c | - |
G | 0 | 0 | 1 | 3* | - |
H | 0 | 0 | 0 | 0 | - |
I | 0 | 0 | 2 | 1b | + |
J | 0 | 0 | 0 | 3 | - |
K | 0 | 0 | 0 | 0 | - |
- Citation: Jacobs AK, Morley SD, Samuel K, Morgan K, Boswell L, Kendall TJ, Dorward DA, Fallowfield JA, Hayes PC, Plevris JN. Hepatic angiotensin-converting enzyme 2 expression in metabolic dysfunction-associated steatotic liver disease and in patients with fatal COVID-19. World J Gastroenterol 2024; 30(31): 3705-3716
- URL: https://www.wjgnet.com/1007-9327/full/v30/i31/3705.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i31.3705